drugset / Trial / NCT00551694

A Second Study to Determine the Effect of GSK256073A on HVTs

NCT00551694

Phase 1 Completed 4 enrolled GlaxoSmithKline
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to compare the effects of single and repeat doses of GSK256073 with placebo in HVT subjects that have been administrated GSK256073 in the HMA107787 study

Timeline

Start
2007-10
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK256073A Unknown Oral

Indications